Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

The editorial introduces various topics on laser and cosmetic treatments in a medical journal.

Tailored treatments for aging brows and foreheads improve results.

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.

Current treatments for androgenetic alopecia are limited, but research is ongoing to find better solutions.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The conclusion is that improved training and oversight for cosmetic procedures are recommended to better protect patients.

The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.

SEFFI is a safe and effective anti-aging treatment with few complications.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Customizing non-invasive treatments for head and neck neuralgia improves patient outcomes.

Interest in new and personalized treatments for hair loss is growing.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

BTA safely and effectively treats hair loss, and works better with FNS.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Botulinum toxin may help treat hair loss by relaxing scalp muscles, improving oxygen and blood flow.

Botulinum toxin affects hair follicles, inhibiting TGF-B1 secretion; more research ongoing.

Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Botulinum toxin is used in many medical fields beyond cosmetic purposes.

Botulinum toxin is not effective or cost-efficient for treating male pattern baldness.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

Botulinum toxin may improve hair transplant success by enhancing graft survival and hair density.

Botulinum toxin may improve hair transplant results by enhancing graft survival and hair density.

Botulinum toxin may improve hair transplant success by enhancing graft survival and hair density.